Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05743335
Status:
COMPLETED
Last Update Posted:
2023-03-17
First Post:
2023-02-22
Brief Title:
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221 an MRNA-based Broadly Protective COVID-19 Vaccine
Sponsor:
Organization:
Immorna Biotherapeutics Inc